We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current IOVA market cap is 2.73B. The company's latest EPS is USD -1.5898 and P/E is -6.10.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 238k | 469k | 482k | 715k |
| Operating Income | -110.86M | -110.09M | -118.36M | -121.26M | -117.72M |
| Net Income | -107.37M | -106.53M | -113.76M | -116.38M | -112.98M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 1.19M |
| Operating Income | -206.87M | -261.94M | -342.7M | -398.88M | -460.56M |
| Net Income | -197.56M | -259.58M | -342.25M | -395.89M | -444.04M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 824.77M | 757.29M | 852.32M | 780.35M | 869.83M |
| Total Liabilities | 157.89M | 178.72M | 178.31M | 195.74M | 189.81M |
| Total Equity | 666.88M | 578.57M | 674.01M | 584.61M | 680.02M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 344.66M | 768.46M | 777.33M | 663.98M | 780.35M |
| Total Liabilities | 45.68M | 111.96M | 155.67M | 164.34M | 195.74M |
| Total Equity | 298.97M | 656.5M | 621.66M | 499.64M | 584.61M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -99.82M | -193.77M | -277.85M | -361.82M | -122.28M |
| Investing | 153.4M | -3.38M | -82.4M | -155.24M | -111.51M |
| Financing | 258.17M | 259.2M | 462M | 462.96M | 193.58M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -158.89M | -205.13M | -227.94M | -292.76M | -361.82M |
| Investing | 90.03M | -317.85M | 132k | 256.46M | -155.24M |
| Financing | 6.13M | 576.42M | 239.27M | 190.15M | 462.96M |
| Market Cap | 2.73B |
| Price to Earnings Ratio | -6.10 |
| Price to Sales Ratio | 2.26k |
| Price to Cash Ratio | 23.58 |
| Price to Book Ratio | 4.63 |
| Dividend Yield | - |
| Shares Outstanding | 279.31M |
| Average Volume (1 week) | 5.53M |
| Average Volume (1 Month) | 6.02M |
| 52 Week Change | 7.70% |
| 52 Week High | 18.33 |
| 52 Week Low | 3.21 |
| Spread (Intraday) | 0.05 (0.51%) |
| Company Name | Iovance Biotherapeutics Inc |
| Address |
2140 s dupont hwy camden, delaware 19934 |
| Website | https://www.iovance.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
